Source link : https://newshealth.biz/health-news/one-glp-1-drug-may-be-better-than-rivals-for-glaucoma-risk/
(MedPage Today) — Use of the dual GIP/GLP-1 drug tirzepatide (Mounjaro, Zepbound) was associated with a significantly reduced risk of glaucoma compared with GLP-1 drugs among patients with type 2 diabetes, a large retrospective cohort study suggested… Source link : https://www.medpagetoday.com/ophthalmology/glaucoma/118988 Author : Publish date : 2025-12-13 13:00:00 Copyright for syndicated content belongs to the […]
The post One GLP-1 Drug May Be Better Than Rivals for Glaucoma Risk first appeared on News Health.
—-
Author : News Health
Publish date : 2025-12-13 13:00:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8